| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/12/2004 | WO2004066725A2 Avermectin- and avermectin monosaccharide derivatives substituted in the 4”- or 4’-position having pesticidal properties |
| 08/12/2004 | WO2004056821A3 Quinolizidine derivatives |
| 08/12/2004 | WO2004056799A3 Substituted 1-piperidin-4-yl-4-pyrrolidin-3-yl-piperazine derivatives and their use as neurokinin antagonists |
| 08/12/2004 | WO2004056762A3 Novel aminobenzophenone compounds |
| 08/12/2004 | WO2004056347A3 Pharmaceutical compositions comprising insulin and legends of insulin hexamer |
| 08/12/2004 | WO2004054638A3 Dermal, transdermal, mucosal or transmucosal ingredient delivery devices |
| 08/12/2004 | WO2004052326A8 Pharmaceutical or cosmetic composition, preventing or reducing itch and local reaction from stings of insects |
| 08/12/2004 | WO2004052287A3 Topical composition for heightened sensitivity |
| 08/12/2004 | WO2004052280A3 Anti-angiogenic compounds and their use in cancer treatment |
| 08/12/2004 | WO2004050092B1 Use of canthin-6-one, plant extracts containing same and derivatives thereof in the treatment of trypanosomiases |
| 08/12/2004 | WO2004050037A3 Lactoferrin in the reduction of circulating cholesterol, vascular inflammation, atherosclerosis and cardiovascular disease |
| 08/12/2004 | WO2004050019A3 Method and compositions for treating anxiety |
| 08/12/2004 | WO2004048551A3 Target for therapy of cognitive impairment |
| 08/12/2004 | WO2004048351A3 Biphenyl compounds which activate ppar-gamma type receptors and use thereof in cosmetic or pharmaceutical compositions |
| 08/12/2004 | WO2004047800A3 Method of drug loading in liposomes by gradient |
| 08/12/2004 | WO2004047734A3 Methods and immune modulatory nucleic acid compositions for preventing and treating disease |
| 08/12/2004 | WO2004047718A3 Process for manufacturing sustained release microbeads containing venlafaxine hci |
| 08/12/2004 | WO2004046120A3 Diaminotriazoles useful as inhibitors of protein kinases |
| 08/12/2004 | WO2004046070A3 Modulation of proteins by phenolic compoudns |
| 08/12/2004 | WO2004045718A3 Treatment of cognitive dysfunctions' |
| 08/12/2004 | WO2004045613A3 Use of domperidone for reducing fertility in mammalian females |
| 08/12/2004 | WO2004045593A3 Combination cancer therapy with a gst-activated anticancer compound and another anticancer therapy |
| 08/12/2004 | WO2004045557A3 Novel lapachone compounds and methods of use thereof |
| 08/12/2004 | WO2004045556A3 Methods for inhibiting allergic inflammation and other responses initiated by pollens, molds, and other non-animal derived allergens |
| 08/12/2004 | WO2004045510A3 Methods and compositions for alleviating dry eyes |
| 08/12/2004 | WO2004045506A3 Conjugated fatty acid based emulsion and methods for preparing and using same |
| 08/12/2004 | WO2004043396A3 Modified carbamate-containing prodrugs and methods of synthesizing same |
| 08/12/2004 | WO2004043392A3 Mucin synthesis inhibitors |
| 08/12/2004 | WO2004043374A3 Methods and compositions for treating cancer using proteasome inhibitors |
| 08/12/2004 | WO2004043362A3 Acyl guanidine compounds and use thereof |
| 08/12/2004 | WO2004039326A3 Propofol with cysteine |
| 08/12/2004 | WO2004039238A3 Modulation of zinc levels to improve tissue properties |
| 08/12/2004 | WO2004037262A3 Immediate release topical pharmaceutical formulation for enhancement of female sexual desire and responsiveness |
| 08/12/2004 | WO2004034976A3 Dihydroartemisinin and dihydroartemisitene dimers as anti-cancer nd anti-infective agents |
| 08/12/2004 | WO2004034889A3 Photodynamic therapy for ocular neovascularization |
| 08/12/2004 | WO2004032908A3 Method of inhibiting angiogenesis |
| 08/12/2004 | WO2004031374A3 Secondary binding site of dipeptidyl peptidase iv (dp iv) |
| 08/12/2004 | WO2004030664A3 New compounds for the inhibition of undesired cell proliferation and use thereof |
| 08/12/2004 | WO2004030635A3 Vasculostatic agents and methods of use thereof |
| 08/12/2004 | WO2004026311A3 Use of specific inhibitors of tyrosine kinases for immunomodulation |
| 08/12/2004 | WO2004026231A3 Formulation for lipophilic agents |
| 08/12/2004 | WO2004024186A3 Treatment of cyclooxygenase-3 mediated diseases and disorders |
| 08/12/2004 | WO2004022032A3 Pharmaceutical dosage form comprising a sulfite compound |
| 08/12/2004 | WO2004021972A3 Pharmaceuticals formulations and methods for modified release of statin drugs |
| 08/12/2004 | WO2004018676A3 Rnai probes targeting cancer-related proteins |
| 08/12/2004 | WO2004015131A3 Hepatitis c virus assays |
| 08/12/2004 | WO2004014308A3 Novel ppar ligands that do not cause fluid retention, edema or congestive heart failure |
| 08/12/2004 | WO2004012664A3 Administration of estradiol metabolites for inhibition of drug-induced nephrotoxicity |
| 08/12/2004 | WO2004009068A3 Compounds with antiparasitic activity and medicines containing same |
| 08/12/2004 | WO2004007531A3 Activated checkpoint therapy and methods of use thereof |
| 08/12/2004 | WO2004007498A9 3-phenyl analogs of toxoflavine as kinase inhibitors |
| 08/12/2004 | WO2004002999A3 Modified 2' and 3' -nucleoside produgs for treating flaviridae infections |
| 08/12/2004 | WO2004002551A3 Inhalable epinephrine |
| 08/12/2004 | WO2003106444A8 N,n-disubstituted diazocycloalkanes useful for the treatment of cns disorders due to serotonergic dysfunction |
| 08/12/2004 | WO2003105774A3 Compounds useful for the treatment of cancer, compositions thereof and methods therewith |
| 08/12/2004 | WO2003105611A9 Beverages containing plant sterols |
| 08/12/2004 | WO2003101390A3 Endobronchial delivery of antibiotic in individuals with impaired lung tissue or lung function |
| 08/12/2004 | WO2003099214A3 Biguanide formulations |
| 08/12/2004 | WO2003093231A3 Tetrahydropyranyl cyclopentyl tetrahydroisoquinoline modulators of chemokine receptor activity |
| 08/12/2004 | WO2003092374A3 Pesticidal heterocycles |
| 08/12/2004 | WO2003079977A3 Novel compositions and methods in cancer associated with altered expression of mcm3ap |
| 08/12/2004 | WO2003037863A3 Substituted indoles, method for production and use thereof for the inhibition of pain |
| 08/12/2004 | WO2003026573A3 Screening and selection methods for statin drug combinations |
| 08/12/2004 | WO2003015606A3 Multicomponent assemblies having enhanced binding properties for diagnosis and therapy |
| 08/12/2004 | WO2002076395A3 Agents and methods for treatment of cancer |
| 08/12/2004 | US20040158288 Method and apparatus for treating tumors using low strength electric fields |
| 08/12/2004 | US20040158143 Stabilized tissue penetrating catheters |
| 08/12/2004 | US20040158092 for example, N-(N-acetyl-L-cysteinyl)-S-acetylcysteamine; by protecting the N-acyl-L-cysteine to form an intermediate compound and then coupling intermediate compound with S-acylcysteamine hydrochloride or with thiazolidine |
| 08/12/2004 | US20040158076 Tyrosine derivatives |
| 08/12/2004 | US20040158075 Organic acid salt of amlodipine |
| 08/12/2004 | US20040158074 Biphenyl sulfonamides as antiinflammatory agents and administering and antipyretics |
| 08/12/2004 | US20040158071 Novel benzylpiperidine compound |
| 08/12/2004 | US20040158066 Compounds for controlling Helicobacteria |
| 08/12/2004 | US20040158048 Compounds that release nitric oxide at controlled rates upon photolysis |
| 08/12/2004 | US20040158045 Nucleotide sequences coding tumor necrosis factor binding proteins for prevention and treatment of bone disorders |
| 08/12/2004 | US20040158035 Substantially pure glycopeptide antibiotics AC-98-1, AC-98-2, AC-98-3, AC-98-4 and AC-98-5 |
| 08/12/2004 | US20040157934 Central nervous system disorders; psychological disorders ; administering dosage og dopamine, serotonin and sibutramine |
| 08/12/2004 | US20040157932 Obesity therapy |
| 08/12/2004 | US20040157930 Histone deacetylase enzyme-inhibiting derivatives of hydroxamic acid as new cytokine synthesis-inhibiting anti-inflammatory drugs |
| 08/12/2004 | US20040157929 Method for increasing serotonin levels in a person by administration of a composition incorporating(-)hydroxycitric acid, and related compositions thereof |
| 08/12/2004 | US20040157928 Controlled disintegration ; concentration; bioavailability; mixture containing surfactant, water and polyoxyethylene glycol; adjust solubility |
| 08/12/2004 | US20040157927 Pharmaceutical combination comprising either (s)-2-ethoxy-3-[4-(2-{4-methane sulfonyl oxyphenyl} ethoxy) phenyl] propanoic acid or 3-{-4-[2-(4-tert-butoxy carbonyl aminophenyl) ethoxy] phenyl}-(s)-2-ethoxy propanoic acid and a sulonylurea |
| 08/12/2004 | US20040157926 Pharmaceutical compositions for the treatment of movement disorders |
| 08/12/2004 | US20040157925 Stable pharmaceutical composition of pravastatin |
| 08/12/2004 | US20040157924 Novel methods for using alkanoyloxymethyl esters |
| 08/12/2004 | US20040157921 Modulation of zinc levels to improve tissue properties |
| 08/12/2004 | US20040157920 Method of adenovirus, HIV and HPV prophylaxis |
| 08/12/2004 | US20040157919 Isomerases inhibitor |
| 08/12/2004 | US20040157918 Weight loss induced by reduction in neuropeptide y level |
| 08/12/2004 | US20040157916 Peptide deformylase inhibitors |
| 08/12/2004 | US20040157915 Combination therapy employing ileal bile acid transport inhibiting benzothiepines and HMG Co-A reductase inhibitors |
| 08/12/2004 | US20040157914 Pyrrolidinone derivatives |
| 08/12/2004 | US20040157913 Irritable bowel syndrome ; gastrointestinal disorders |
| 08/12/2004 | US20040157912 8-Azaprostaglandin analogs as agents for lowering intraocular pressure |
| 08/12/2004 | US20040157911 Storage-stable and bio-stable formulations of ace inhibitors, and methods for preparation thereof |
| 08/12/2004 | US20040157910 Restless leg syndrome; administering ropinirole, or salt thereof |
| 08/12/2004 | US20040157909 Modulating protein kinase signal transduction; anticancer agents |
| 08/12/2004 | US20040157908 (-)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions thereof, and uses as a dopamine-reuptake inhibitor |
| 08/12/2004 | US20040157905 Administering protoporhyrin ix ; detection accumulation in cells; measurement cell proliferation |
| 08/12/2004 | US20040157903 Antidiabetic agents; synergistic mixture |